Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies
Medical College of Wisconsin
Medical College of Wisconsin
University of Texas Southwestern Medical Center
University of California, San Francisco
National Cancer Institute (NCI)